drugset / Trial / NCT01016782

Study of 0444 Gel in the Treatment of Inflammatory Lesions of Rosacea

NCT01016782

Phase 3 Completed 867 enrolled Fougera Pharmaceuticals Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this trial is to assess the efficacy of Metronidazole Topical Gel 1% in the Treatment of Inflammatory Lesions of Rosacea. Treatment medication will be administered as follows: A thin film of gel will be applied and rubbed into the entire face once daily for a period of 70 days.

Timeline

Start
2008-01
Primary completion
2009-07
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Metronidazole Small molecule 1 % Topical

Indications